Factor-sparing use of the COX-2 inhibitor rofecoxib in haemophilic arthropathy.

G. Bragadóttir*, P. T. Onundarson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)832-833
Number of pages2
JournalHaemophilia : the official journal of the World Federation of Hemophilia
Volume8
Issue number6
DOIs
Publication statusPublished - Nov 2002

Cite this